AULT MILTON C III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-11-15 4:30 pm Purchase |
2022-11-11 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 292,144 43.200% |
9,689![]() (+3.43%) |
Filing |
2022-04-28 07:00 am Purchase |
2022-04-26 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 282,455 43.200% |
20,712![]() (+7.91%) |
Filing |
2021-08-04 09:35 am Purchase |
2021-07-30 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 261,744 42.300% |
797![]() (+0.31%) |
Filing |
2021-06-25 4:30 pm Purchase |
2021-06-14 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 260,947 41.600% |
260,947![]() (New Position) |
Filing |